Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells
- PMID: 12714333
- DOI: 10.1152/ajpheart.00254.2003
Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells
Abstract
Placental growth factor (PlGF) competes with vascular endothelial growth factor (VEGF) for binding to VEGF receptor (VEGFR)-1 but does not bind VEGFR2. Experiments show that PlGF can augment the response to VEGF in pathological angiogenesis and in models of endothelial cell survival, migration, and proliferation. This synergy has been hypothesized to be due to a combination of the following: signaling by PlGF through VEGFR1 and displacement of VEGF from VEGFR1 to VEGFR2 by PlGF, causing increased signaling through VEGFR2. In this study, the relative contribution of PlGF-induced VEGF displacement to the synergy is quantified using a mathematical model of ligand-receptor binding to examine the effect on ligand-receptor complex formation of VEGF and PlGF acting together. Parameters specific to the VEGF-PlGF system are used based on existing data. The model is used to simulate in silico a specific in vitro experiment in which VEGF-PlGF synergy is observed. We show that, whereas a significant change in the formation of endothelial surface growth factor-VEGFR1 complexes is predicted in the presence of PlGF, the increase in the number of VEGFR2-containing signaling complexes is less significant; these results were shown to be robust to significant variation in the kinetic parameters of the model. Synergistic effects observed in that experiment thus appear unlikely to be due to VEGF displacement but to a shift from VEGF-VEGFR1 to PlGF-VEGFR1 complexes and an increase in total VEGFR1 complexes. These results suggest that VEGFR1 signaling can be functional in adult-derived endothelial cells.
Similar articles
-
Placenta growth factor and vascular endothelial growth factor B expression in the hypoxic lung.Respir Res. 2011 Jan 25;12(1):17. doi: 10.1186/1465-9921-12-17. Respir Res. 2011. PMID: 21266048 Free PMC article.
-
The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.Sci Signal. 2013 Jul 2;6(282):ra52. doi: 10.1126/scisignal.2003905. Sci Signal. 2013. PMID: 23821770
-
A computational analysis of in vivo VEGFR activation by multiple co-expressed ligands.PLoS Comput Biol. 2017 Mar 20;13(3):e1005445. doi: 10.1371/journal.pcbi.1005445. eCollection 2017 Mar. PLoS Comput Biol. 2017. PMID: 28319199 Free PMC article.
-
VEGFR1 signaling in retinal angiogenesis and microinflammation.Prog Retin Eye Res. 2021 Sep;84:100954. doi: 10.1016/j.preteyeres.2021.100954. Epub 2021 Feb 25. Prog Retin Eye Res. 2021. PMID: 33640465 Free PMC article. Review.
-
VEGF-A-stimulated signalling in endothelial cells via a dual receptor tyrosine kinase system is dependent on co-ordinated trafficking and proteolysis.Biochem Soc Trans. 2009 Dec;37(Pt 6):1193-7. doi: 10.1042/BST0371193. Biochem Soc Trans. 2009. PMID: 19909245 Review.
Cited by
-
Modeling Tumor-Associated Edema in Gliomas during Anti-Angiogenic Therapy and Its Impact on Imageable Tumor.Front Oncol. 2013 Apr 4;3:66. doi: 10.3389/fonc.2013.00066. eCollection 2013. Front Oncol. 2013. PMID: 23577324 Free PMC article.
-
Mathematical models of the VEGF receptor and its role in cancer therapy.J R Soc Interface. 2007 Apr 22;4(13):283-304. doi: 10.1098/rsif.2006.0170. J R Soc Interface. 2007. PMID: 17251148 Free PMC article.
-
Quantification and cell-to-cell variation of vascular endothelial growth factor receptors.Exp Cell Res. 2011 Apr 15;317(7):955-65. doi: 10.1016/j.yexcr.2010.12.014. Epub 2010 Dec 23. Exp Cell Res. 2011. PMID: 21185287 Free PMC article.
-
Hypoxia inducible factors-mediated inhibition of cancer by GM-CSF: a mathematical model.Bull Math Biol. 2012 Nov;74(11):2752-77. doi: 10.1007/s11538-012-9776-3. Epub 2012 Oct 17. Bull Math Biol. 2012. PMID: 23073704 Free PMC article.
-
Therapeutic angiogenesis for critical limb ischaemia.Nat Rev Cardiol. 2013 Jul;10(7):387-96. doi: 10.1038/nrcardio.2013.70. Epub 2013 May 14. Nat Rev Cardiol. 2013. PMID: 23670612 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources